Cargando…
Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
BACKGROUND: Recent studies have revealed the endocannabinoid system as a potential therapeutic target in the management of nonalcoholic fatty liver disease (NAFLD). Cannabis use is associated with reduced risk for NAFLD, we hypothesized that cannabis use would be associated with less liver-related c...
Autores principales: | Choi, Catherine J, Weiss, Stanley H, Nasir, Umair M, Pyrsopoulos, Nikolaos T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701971/ https://www.ncbi.nlm.nih.gov/pubmed/33312424 http://dx.doi.org/10.4254/wjh.v12.i11.993 |
Ejemplares similares
-
Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
por: Jiang, Yi, et al.
Publicado: (2021) -
Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease
por: Delicce, Michael, et al.
Publicado: (2022) -
Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022) -
Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Tan, You-Wen, et al.
Publicado: (2023) -
Hospital teaching status on the outcomes of patients with esophageal variceal bleeding in the United States
por: Patel, Pavan, et al.
Publicado: (2020)